Drugs / UK-432,097
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00430300 | Jan 2007 → Jul 2008 | chronic obstructive pulmonary disease | Pfizer | Terminated | Missed primary |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UK-432,097 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00430300 ↗ |
| Action | Activate | “Adenosine A2a receptor agonist” CHEMBL1096896 ↗ |
| Modality | Small molecule | — CHEMBL1096896 ↗ |
| Route | Inhaled | “Dry Powder For Inhalation” NCT00430300 ↗ |
| Target | ADORA2A | “Adenosine A2a receptor agonist” CHEMBL1096896 ↗ |